radiolabeled imaging agent (Clarity Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameradiolabeled imaging agent (Clarity Pharmaceuticals)
Drug Alias Nameneurological diseases biological compound (Clarity)
ClassificationRadiation-emitting productsSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesClarity Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClarity Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A